Changes

no edit summary
Line 6: Line 6:     
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
+
__TOC__
 
<br />
 
<br />
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
Line 19: Line 19:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
|CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)
+
|
 +
====CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)====
 
|
 
|
 
----
 
----
Line 121: Line 122:  
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Ductal adenoma||Disease||
 
|Ductal adenoma||Disease||
Line 211: Line 223:  
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Lobular carcinoma in situ||Disease||
 
|Lobular carcinoma in situ||Disease||
Line 301: Line 324:  
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Carcinoma with apocrine differentiation||Disease||
 
|Carcinoma with apocrine differentiation||Disease||
Line 392: Line 426:  
|
 
|
 
|-
 
|-
|CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|
 +
====CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)====
 
|
 
|
 
----
 
----
Line 439: Line 485:  
|2021 template added
 
|2021 template added
 
|-
 
|-
|CHAPTER 4 (TUMOURS OF THE NIPPLE)
+
|
 +
====CHAPTER 4 (TUMOURS OF THE NIPPLE)====
 
|
 
|
 
----
 
----
Line 486: Line 533:  
|
 
|
 
|-
 
|-
|CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)
+
|
 +
====CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)====
 
|
 
|
 
----
 
----
Line 514: Line 562:  
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Angiomatosis||Disease||
 
|Angiomatosis||Disease||
Line 604: Line 663:  
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Granular cell tumour||Disease||
 
|Granular cell tumour||Disease||
Line 668: Line 738:  
|
 
|
 
|-
 
|-
|CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)
+
|
 +
====CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)====
 
|
 
|
 
----
 
----
Line 705: Line 776:  
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Diffuse large B-cell lymphoma||Disease||
 
|Diffuse large B-cell lymphoma||Disease||
Line 733: Line 815:  
|
 
|
 
|-
 
|-
|CHAPTER 7 (TUMOURS OF THE MALE BREAST)
+
|
 +
====CHAPTER 7 (TUMOURS OF THE MALE BREAST)====
 
|
 
|
 
----
 
----
Line 789: Line 872:  
|
 
|
 
|-
 
|-
|CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)
+
|
 +
====CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)====
 
|
 
|
 
----
 
----
Line 818: Line 902:  
|N/A
 
|N/A
 
|-
 
|-
|Cowden syndrome||Disease||[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[BRST5:Cowden syndrome|Cowden syndrome]]||Disease||[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
 
|N/A
 
|N/A
 
|N/A
 
|N/A
Line 881: Line 976:  
|N/A
 
|N/A
 
|-
 
|-
|Neurofibromatosis type 1||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
+
|[[GTS5:Neurofibromatosis type 1 (NF1)|Neurofibromatosis type 1]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 
|N/A
 
|N/A
 
|N/A
 
|N/A